Indian drug producer Riemann Labs has been requested to halt manufacturing after its cough syrup was linked to a string of deaths amongst youngsters in Cameroon.
In a written response to a lawmaker’s query learn out in parliament, the Indian Health Ministry mentioned the World Health Organization (WHO) had issued alerts and requested for info on 4 instances of syrup merchandise exported from India.
“Subsequent to the reports, the Central Drugs Standard Control Organization in coordination with State Drug Controllers carried out joint investigations,” the ministry mentioned.
A joint inspection was carried out at Riemann Labs within the state of Madhya Pradesh and primarily based on the findings the drug authorities directed the agency to cease manufacturing, the ministry mentioned.
MYSTERY DEATHS
Indian every day Mint reported in June that “more than a dozen children have passed away in Cameroon over the past few months with authorities linking it to a cough syrup potentially made in India.”
India is in a repair after Indian-made cough syrups had been linked to the deaths of dozens of youngsters in overseas nations.
Last month, Indian drug regulators mentioned that they’ve halted manufacturing at 31 companies after finishing up an intensive inspection and audit.
In April, WHO issued an alert relating to contaminated cough syrup made by an Indian firm which it recognized within the Marshall Islands and Micronesia.
In March, Indian well being authorities canceled the license of Marion Biotech after a cough syrup it manufactured was linked to the deaths of not less than 19 youngsters in Uzbekistan final 12 months. Three individuals have been arrested within the case.
In February, one other Indian agency, Global Pharma Healthcare recalled its eye drops after the U.S. flagged 55 instances of antagonistic results, together with one dying.
The incident in Uzbekistan adopted an identical case in Gambia in October final 12 months when the WHO issued an alert for 4 contaminated medicines linked to acute kidney accidents and 66 little one deaths.
The medicines had been cough and chilly syrups manufactured by Maiden Pharmaceuticals Limited in India. Subsequently, the agency was requested to halt manufacturing.
Source: www.anews.com.tr
